Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended		82 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012
Cash flows from operating activities:
Net income (loss)	$ 13,379,619	$ 418,921	$ (34,437,195)
Adjustments to reconcile net (loss) to net cash used in operating activities:
Depreciation and amortization expense	218,579	101,599	456,206
Non-cash derivatives (gain) losses	(21,436,653)	(6,559,835)	8,581,508
Non-cash interest expense			962,834
Common stock issued to 401(k) plan	60,906		102,568
Common stock issued for services	24,750	200,676	234,201
Share-based compensation expense	823,617	622,141	2,623,969
Changes in operating assets and liabilities:
Restricted cash	(86,867)	(155,000)	(634,750)
Prepaid expenses	(22,237)	(28,306)	(116,208)
Other assets		(75,000)	(200,000)
Accounts payable	574,072	216,862	1,141,267
Accrued interest payable			(15,256)
Accrued expenses	143,570	111,534	761,939
Net cash used in operating activities	(6,320,644)	(5,146,408)	(20,538,917)
Cash flows from investing activities:
Purchases of property and equipment	(1,709,496)	(241,995)	(2,340,204)
Net cash used in investing activities	(1,709,496)	(241,995)	(2,340,204)
Cash flows from financing activities :
Proceeds from issuance of convertible notes payable			4,181,000
Proceeds from convertible bridge notes			500,000
Proceeds from (repayment of) loans payable	112,289	(17,353)	246,661
Principal payments on capital lease obligation	(20,294)	118,057	(45,068)
Proceeds from issuance of common stock and warrants	19,124,042	10,434	33,546,137
Net cash provided by (used in) financing activities	19,216,037	111,138	38,428,730
Increase (decrease) in cash and cash equivalents	11,185,897	(5,277,265)	15,549,609
Cash and cash equivalents at beginning of period	4,363,712	8,964,194
Cash and cash equivalents at end of period	$ 15,549,609	$ 3,686,929	$ 15,549,609